Ataxion competitors

Ataxion Competitors include Opiant Pharmaceuticals, IntelGenx, Generex Biotechnology and E-Therapeutics.
Add company...
Ataxion
Ataxion
Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
IntelGenx
IntelGenx
IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.
Generex Biotechnology
Generex Biotechnology
Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.
E-Therapeutics
E-Therapeutics
e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.
Founding Date
Founding Date
2013
Founding Date
2009
Founding Date
2003
Founding Date
N/A
Founding Date
2003
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Santa Monica, US HQ
Locations
Saint-Laurent, CA HQ
Locations
Burlington, CA HQ
Locations
Long Hanborough, GB HQ
Employees
Employees
N/A
Employees
14367% increase
Employees
12
Employees
363% decrease
Employees
2017% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
60.6 m
Valuation ($)
50.1 m
Valuation ($)
3.1 m
Valuation ($)
36.1 m
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1 k
Twitter followers
422
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$18.4m (FY, 2017)
Revenue (est.)
$5.2m (FY, 2017)
Revenue (est.)
$703.2k (FY, 2018)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
$6.6m (FY, 2017)
Net income
($3.1m) (FY, 2017)
Net income
$35.9m (FY, 2018)
Net income
(£5.4m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 17m
Total funding raised
N/A
Total funding raised
$ 1.7m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
14

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
IntelGenx
HQ
Saint-Laurent, CA
Employees
12

IntelGenx is a drug delivery company focused on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market.

View company
Generex Biotechnology
HQ
Burlington, CA
Employees
3

Generex Biotechnology develops and commercializesdrug delivery systems and technologies for metabolic and immunological diseases.

View company
E-Therapeutics
HQ
Long Hanborough, GB
Employees
20↓ 17% decrease

e-Therapeutics is a drug discovery and development company based in Oxford and Newcastle, UK. The Company is a pioneer of network pharmacology, a distinctive new approach to the discovery of medicines.

View company